128 related articles for article (PubMed ID: 8208961)
1. Prostate cancer: are racial differences in clinical stage and survival explained by differences in symptoms?
Lawton CA; Cantrell JE; Derus SW; Murray KJ; Byhardt RW; Wilson JF
Radiology; 1994 Jul; 192(1):37-40. PubMed ID: 8208961
[TBL] [Abstract][Full Text] [Related]
2. Carcinoma of the prostate: race as a prognostic indicator in definitive radiation therapy.
Kim JA; Kuban DA; el-Mahdi AM; Schellhammer PF
Radiology; 1995 Feb; 194(2):545-9. PubMed ID: 7529936
[TBL] [Abstract][Full Text] [Related]
3. Incidence, racial differences, and prognostic significance of prostate carcinomas diagnosed with obstructive symptoms.
Brawn PN; Johnson EH; Speights VO; Riggs M; Kuhl D; Abel PD; Lind M; Bell N
Cancer; 1994 Sep; 74(5):1607-11. PubMed ID: 8062192
[TBL] [Abstract][Full Text] [Related]
4. Age-race interaction in prostatic adenocarcinoma treated with external beam irradiation.
Austin JP; Convery K
Am J Clin Oncol; 1993 Apr; 16(2):140-5. PubMed ID: 8452106
[TBL] [Abstract][Full Text] [Related]
5. Race and cause specific survival with prostate cancer: influence of clinical stage, Gleason score, age and treatment.
Fowler JE; Bigler SA; Bowman G; Kilambi NK
J Urol; 2000 Jan; 163(1):137-42. PubMed ID: 10604331
[TBL] [Abstract][Full Text] [Related]
6. Prostate-specific antigen values at the time of prostate cancer diagnosis in African-American men.
Moul JW; Sesterhenn IA; Connelly RR; Douglas T; Srivastava S; Mostofi FK; McLeod DG
JAMA; 1995 Oct; 274(16):1277-81. PubMed ID: 7563532
[TBL] [Abstract][Full Text] [Related]
7. Prospective study of cancer detection in black and white men with normal digital rectal examination but prostate specific antigen equal or greater than 4.0 ng/mL.
Fowler JE; Bigler SA; Farabaugh PB
Cancer; 2002 Mar; 94(6):1661-7. PubMed ID: 11920526
[TBL] [Abstract][Full Text] [Related]
8. Racial differences in adenocarcinoma of the prostate in North American men.
Morton RA
Urology; 1994 Nov; 44(5):637-45. PubMed ID: 7526522
[TBL] [Abstract][Full Text] [Related]
9. A prospective study of the serum prostate specific antigen concentrations and Gleason histologic scores of black and white men with prostate carcinoma.
Fowler JE; Bigler SA
Cancer; 1999 Sep; 86(5):836-41. PubMed ID: 10463983
[TBL] [Abstract][Full Text] [Related]
10. Use of lower prostate specific antigen cutoffs for prostate cancer screening in black and white men.
Smith DS; Carvalhal GF; Mager DE; Bullock AD; Catalona WJ
J Urol; 1998 Nov; 160(5):1734-8. PubMed ID: 9783942
[TBL] [Abstract][Full Text] [Related]
11. Prostate carcinoma patients upstaged by imaging and treated with irradiation. An outcome-based analysis.
Pinover WH; Hanlon A; Lee WR; Kaplan EJ; Hanks GE
Cancer; 1996 Apr; 77(7):1334-41. PubMed ID: 8608512
[TBL] [Abstract][Full Text] [Related]
12. Radiation-treated carcinoma of prostate. Comparison of survival of black and white patients by Gleason's grading system.
Aziz H; Rotman M; Thelmo W; Chen P; Choi KN; Khil SU; Laungani GB; Brandys M; Ayr G; Macchia RJ
Am J Clin Oncol; 1988 Apr; 11(2):166-71. PubMed ID: 3358363
[TBL] [Abstract][Full Text] [Related]
13. Effect of age and race on the survival of men with prostate cancer in the Metropolitan Detroit tricounty area, 1973 to 1987.
Pienta KJ; Demers R; Hoff M; Kau TY; Montie JE; Severson RK
Urology; 1995 Jan; 45(1):93-101; discussion 101-2. PubMed ID: 7817485
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of correlations between biopsy-detected high grade prostatic intraepithelial neoplasia, serum prostate specific antigen concentration, and race.
Fowler JE; Bigler SA; Lynch C; Wilson SS; Farabaugh PB
Cancer; 2001 Apr; 91(7):1291-6. PubMed ID: 11283929
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in mortality among Medicare recipients after treatment for localized prostate cancer.
Godley PA; Schenck AP; Amamoo MA; Schoenbach VJ; Peacock S; Manning M; Symons M; Talcott JA
J Natl Cancer Inst; 2003 Nov; 95(22):1702-10. PubMed ID: 14625261
[TBL] [Abstract][Full Text] [Related]
16. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
[TBL] [Abstract][Full Text] [Related]
17. Racial Disparities in the Presentation, Early Definitive Surgical Treatment, and Mortality Among Men Diagnosed with Poorly Differentiated/Undifferentiated Non-metastatic Prostate Cancer in the USA.
Lediju O; Ikuemonisan J; Salami SS; Adejoro O
J Racial Ethn Health Disparities; 2019 Apr; 6(2):401-408. PubMed ID: 30506310
[TBL] [Abstract][Full Text] [Related]
18. Racial differences in prostate-specific antigen levels and prostate-specific antigen densities in patients with prostate cancer.
Abdalla I; Ray P; Vaida F; Vijayakumar S
Am J Clin Oncol; 1999 Dec; 22(6):537-41. PubMed ID: 10597735
[TBL] [Abstract][Full Text] [Related]
19. Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system.
Optenberg SA; Thompson IM; Friedrichs P; Wojcik B; Stein CR; Kramer B
JAMA; 1995 Nov 22-29; 274(20):1599-605. PubMed ID: 7474244
[TBL] [Abstract][Full Text] [Related]
20. Clinical stage T1c prostate cancer: pathologic outcomes following radical prostatectomy in black and white men.
Eastham JA; Carver B; Katz J; Kattan MW
Prostate; 2002 Mar; 50(4):236-40. PubMed ID: 11870801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
